Bristol-Myers Squibb Company (BMY) earnings · P/E 13, rev $48.19B
These earnings events as JSON? API free 100/dayBristol-Myers Squibb Company (BMY) is a drug manufacturers - general company listed on US. It is led by Christopher S. Boerner Ph.D..
This BMY earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported BMY revenue for 2025-12-31 was $48.19B. Net income was $7.05B. Revenue was down 0.2% from 2024-12-31 to 2025-12-31. BMY currently screens at market cap $95.36B and trailing P/E 13.3.
When the next BMY 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was down 0.2% from 2024-12-31 to 2025-12-31. An earnings headline that ignores that move is noise.
Not investment advice. Full BMY research stays on the stock page; the tape stays on the quote page.
BMY earnings FAQ
What are BMY's latest revenue and net income?
Latest cached Bristol-Myers Squibb Company (BMY) revenue for Dec 31, 2025 was $48.19B. Net income was $7.05B. Statements: https://lician.com/financials/bmy
What is BMY's latest diluted EPS?
Latest cached Bristol-Myers Squibb Company (BMY) diluted EPS for Dec 31, 2025 was $3.46.
What period does the latest BMY earnings print cover?
The latest cached Bristol-Myers Squibb Company (BMY) earnings print covers Dec 31, 2025. The prior cached period on this page is Dec 31, 2024.
How did BMY revenue change from the prior cached period?
Cached Bristol-Myers Squibb Company (BMY) revenue was down 0.2% from $48.30B (Dec 31, 2024) to $48.19B (Dec 31, 2025). Statements: https://lician.com/financials/bmy
What is BMY's P/E ratio?
Bristol-Myers Squibb Company (BMY) trailing P/E is 13.3 on the latest cached fundamentals snapshot.
Where are BMY earnings listed?
Cached earnings facts for Bristol-Myers Squibb Company (BMY) are listed at https://lician.com/earnings/bmy. Statements: https://lician.com/financials/bmy
Not investment advice.